MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.

about

MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.

Item

http://www.wikidata.org/entity/Q55194814

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@en

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@nl

type

Item

label

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@en

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@nl

prefLabel

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@en

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@nl

P1476

MR imaging biomarkers evaluati ...... w after anti-vessel treatment.

@en

P2093

Chengde Liao

http://www.w3.org/2001/XMLSchema#string

Guangjun Yang

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

Qinqing Li

http://www.w3.org/2001/XMLSchema#string

Tengfei Ke

http://www.w3.org/2001/XMLSchema#string

Yifan Liu

http://www.w3.org/2001/XMLSchema#string

Yingying Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.

DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.

Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs

Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.

A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment.

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.

P304

11964-11976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22600

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29552285

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5844721

http://www.w3.org/2001/XMLSchema#string